Top Markets
Coin of the day
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Rangering i aksjer #31791
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Aksjekurs
$0.21291741
Sist synkronisert: 2025-04-18
Markedsverdi
$12.07M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
KR
Handel PCL, Inc. (241820)

Kategori

Inntekter for PCL, Inc. (241820)
Inntekter i Sep 2025 TTM: $-33.90M
Ifølge PCL, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat $-33.90M. I 2023 hadde selskapet et resultat på $-15.73M, en nedgang sammenlignet med resultatet i 2022, som var $-3.18M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for PCL, Inc. fra 2015 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-33.90M -5.68%
2024 $-35.94M 128.48%
2023 $-15.73M 394.91%
2022 $-3.18M -88.07%
2021 $-26.64M -248.25%
2020 $17.97M -360.49%
2019 $-6.90M 33.10%
2018 $-5.18M 42.76%
2017 $-3.63M 87.03%
2016 $-1.94M 22.38%
2015 $-1.59M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$7.51B -22,254.56%
US
$5.15B -15,284.62%
US
$5.56B -16,508.71%
IE
$3.86B -11,488.46%
US
$1.42B -4,281.37%
US